Our response to Covid-19 crisis
No compromises on safety, total commitment to supporting your research!
News
Hot off the press! Fresh news from Cisbio!
PerkinElmer Acquires Cisbio
Cisbio takes the next step forward in its development joining PerkinElmer
STING pathway investigation
Cisbio extends its assay portfolio for immuno-oncology drug discovery wi...
New partnership with Excellerate Bioscience
Excellerate Bioscience and Cisbio announce the launch of a collaboration...